Related Experiment Video
Updated: Jul 20, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
Published on: July 7, 2023
Point-counterpoint: the importance of "open access" to psychotropics for our patients
Alan D Schmetzer1, John J Wernert
1Department of Psychiatry, Indiana University School of Medicine, 1111 W 10th St, Indianapolis, IN 26202-4800, USA. aschmetz@iupui.edu
Abstract:
The opposing arguments regarding so-called "open access" to psychotropic medicines for all physicians are outlined, with references. The reader is left to draw conclusions from the discussion or to utilize the points in presentations to politicians, the media, pharmacy and therapeutics committees, state Medicaid agencies, etc.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Psychosis and Antipsychotic Drugs: Overview
The Placebo Effect
Antidepressant Drugs: Overview

